Erste Asset Management Gmb H Inhibrx, Inc. Transaction History

Erste Asset Management Gmb H

  • $8.35 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Nov 26, 2024
SELL
$14.06 - $35.08 $122,322 - $305,196
-8,700 Closed
0 $0
Q3 2022

Nov 26, 2024
BUY
$11.58 - $24.73 $100,746 - $215,151
8,700 New
8,700 $152 Million
Q2 2022

Nov 26, 2024
BUY
$8.52 - $25.26 $74,124 - $219,762
8,700 New
8,700 $104 Million
Q1 2022

Nov 22, 2024
BUY
$19.89 - $43.18 $173,043 - $375,666
8,700 New
8,700 $194 Million

Others Institutions Holding INBX

# of Institutions
1
Shares Held
18.6K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $565M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email